Related Experiment Video
Updated: Jul 18, 2026

Heterokaryon Technique for Analysis of Cell Type-specific Localization
Published on: March 11, 2011
Topoisomerase II binds importin alpha isoforms and exportin/CRM1 but does not shuttle between the nucleus and
Shelagh E L Mirski1, Kathryn E Sparks, Beate Friedrich
1Division of Cancer Biology and Genetics, Cancer Research Institute, Queen's University, Kingston, ON, Canada K7L 3N6.
Abstract:
Resistance to anticancer drugs that target DNA topoisomerase II (topo II) isoforms alpha and/or beta is associated with decreased nuclear and increased cytoplasmic topo IIalpha. Earlier studies have confirmed that functional nuclear localization and export signal sequences (NLS and NES) are present in both isoforms. In this study, we show that topo II alpha and beta bind and are imported into the nucleus by importin alpha1, alpha3, and alpha5 in conjunction with importin beta. Topo IIalpha also binds exportin/CRM1 in vitro. However, wild-type topo IIalpha has only been observed in the cytoplasm of cells that are entering plateau phase growth. This suggests that topo IIalpha may shuttle between the nucleus and the cytoplasm with the equilibrium towards the nucleus in proliferating cells but towards the cytoplasm in plateau phase cells. The CRM1 inhibitor Leptomycin B increases the nuclear localization of GFP-tagged topo IIalpha with a mutant NLS, suggesting that its export is being inhibited. However, homokaryon shuttling experiments indicate that fluorescence-tagged wild-type topo II alpha and beta proteins do not shuttle in proliferating Cos-1 or HeLa cells. We conclude that topo II alpha and beta nuclear export is inhibited in proliferating cells so that these proteins do not shuttle.
Insights
DNA topoisomerase II (topo II) nuclear export is inhibited in proliferating cells, preventing shuttling. This explains how topo IIalpha accumulates in the nucleus during cell growth, impacting anticancer drug resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Anticancer drug resistance targeting DNA topoisomerase II (topo II) is linked to altered topo IIalpha localization.
- Both topo II alpha and beta isoforms possess nuclear localization and export signals.
Purpose of the Study:
- To investigate the nuclear import and export mechanisms of topo II alpha and beta.
- To understand the role of topo II localization in cellular proliferation and drug resistance.
Main Methods:
- In vitro binding assays with importins and exportin/CRM1.
- Analysis of GFP-tagged topo IIalpha localization in cells treated with Leptomycin B.
- Homokaryon shuttling experiments in Cos-1 and HeLa cells.
Main Results:
- Topo II alpha and beta bind importins for nuclear import.
- Topo IIalpha binds exportin/CRM1 in vitro.
- Nuclear export of topo II alpha and beta appears inhibited in proliferating cells, preventing shuttling.
Conclusions:
- Topo II nuclear export is actively inhibited in proliferating cells.
- This inhibition maintains nuclear localization of topo II, potentially influencing drug response.
- Altered nucleocytoplasmic shuttling of topo II isoforms is a key factor in cellular response to anticancer therapies.
More Related Videos
Related Concept Videos
Nuclear Localization Signals and Import
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Directionality of Nuclear Transport
Regulation of Nuclear Protein Sorting
Nuclear Export of mRNA
